PRESS RELEASE: Group Figures for the 2011/2012 Financial Year: Analytik Jena Exceeds Forecasts and Confirms Preliminary Figures

Analytik Jena AG / Group Figures for the 2011/2012 Financial Year: Analytik Jena Exceeds Forecasts and Confirms Preliminary Figures . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.

- Best revenue performance in the Company's history - Operating earnings up 21.7 % to EUR 6.1 m - Executive and Supervisory Board to propose the distribution of a dividend of EUR 0.20 per share to the Annual General Meeting

Jena (Germany), December 18, 2012 - Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) closed the 2011/2012 financial year with the best revenue performance in its history and significant growth in income. With revenue increasing by 8.9 % and operating earnings up 21.7 %, Analytik Jena exceeded its expectations for the past financial year, in some cases significantly. The Company reported consolidated revenue of EUR 94.0 m, while earnings before interest and taxes (EBIT) for the period under review amounted to EUR 6.1 m. At their meeting yesterday, Executive and Supervisory Board decided to propose to the Annual General Meeting the distribution of a dividend of EUR 0.20 per share.

"We can look back on a highly successful financial year. The fact that we were able to record solid operating earnings despite the difficult market environment in Europe is primarily attributable to the consistently strong revenue in our core Analytical Instrumentation business unit throughout the year and our excellent market position in Asia," commented Klaus Berka, CEO of Analytik Jena AG.

Revenue Performance and Segments

Analytik Jena closed the financial year with total revenue in its largest segment, Analytical Instrumentation, of EUR 60.0 m (previous year: EUR 53.2 m), corresponding to revenue growth of 12.8 %. The Life Science business unit generated revenue of EUR 28.2 m, a figure that was largely unchanged as against the previous year (EUR 28.3 m). Revenue in the Optics segment totaled EUR 5.8 m in the 2011/2012 financial year, an increase of 20.8 % (previous year: EUR 4.8 m).

"We are working intensively on the international positioning of the comparatively young Life Science segment, and have made progress in some important areas. For example, double-digit growth in revenue from PCR products and reagents meant that we were able to compensate for the lower revenue from two subsidiaries. In the Optics segment, we have leveraged new revenue and earnings potential as an OEM provider for optical modules and devices," Berka continued.

Goods with a total value of EUR 39.2 m were exported to Asia (previous year: EUR 29.9 m). This represents further revenue growth of 30.8 % in what is Analytik Jena's most important sales region. In Germany, the second-largest sales market after Asia, revenue amounted to EUR 25.3 m (previous year: EUR 24.4 m). Despite the European sovereign debt crisis, business in the Company's domestic market remained stable. Revenue in the Europe region (excluding Germany) declined by 14.5 % year-on-year to EUR 20.1 m (previous year: EUR 23.5 m). There was positive development in the America sales region, where revenue amounted to EUR 6.9 m (previous year: EUR 6.1 m). All in all, the Group exported goods with a value of EUR 68.7 m (previous year: EUR 61.9 m), corresponding to an export ratio of 73.1 % after 71.7 % in the previous year.

Financial Position and Results of Operations

Analytik Jena closed the 2011/2012 financial year with earnings and income growth that was in line with and, in some cases, significantly ahead of expectations. The Group recorded earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 10.2 m, a year-on-year increase of 15.6 % (previous year: EUR 8.8 m), and generated a double-digit EBITDA margin of 10.8 % (previous year: 10.2 %). In terms of its operating result, too, Analytik Jena enjoyed solid development in the past financial year, reporting double-digit growth of 21.7 % as against the previous year. The Company closed the period under review with earnings before interest and taxes (EBIT) of EUR 6.1 m (previous year: EUR 5.0 m). The EBIT margin increased by 0.7 percentage points, from 5.8 % in the previous year to 6.5 %.

For long periods of the financial year, earnings before taxes (EBT) benefited from the favorable exchange rate situation for export-oriented companies, which allowed Analytik Jena to record a significantly improved financial result compared with the previous year. In the 2011/2012 financial year, the Group generated a pre-tax profit of EUR 5.0 m (previous year: EUR 2.8 m), corresponding to an increase of 78.9 %. Consolidated tax expense amounted to EUR 1.5 m (previous year: EUR 2.6 m). Consolidated net profit for the financial year amounted to EUR 3.5 m (previous year: EUR 0.2 m). After deducting non- controlling interests, the Group generated net profit attributable to the shareholders of the parent company of EUR 3.3 m as of September 30, 2012 (previous year: net loss of EUR 0.2 m). Including income components taken directly to equity, Analytik Jena recorded total comprehensive income of EUR 3.4 m (previous year: EUR 0.3 m). Basic and diluted earnings per share both amounted to EUR 0.59 (previous year: EUR -0.03).

The Group's total assets saw significant growth of 26.3 %, from EUR 83.6 m in the previous year to EUR 105.7 m as of September 30, 2012. The main reasons for this development were the substantial rise in liquidity on the asset side and the small capital increase conducted in early 2012 and the conclusion of new borrower's note loan on the equity and liability side.

Human Resources

As of September 30, 2012, the Group had a total of 827 employees, of which 45 were interns (previous year: 802 employees, 38 interns), a year-on-year increase of 3.1 %.

Outlook

For the 2012/2013 financial year, Analytik Jena expects to again increase consolidated revenue and earnings across all areas of the Group. "The aim of the Analytik Jena Group for the coming year is to further reinforce and expand our position on the global markets. Our objectives are to generate further revenue growth, exceed the highs recorded in 2011/2012, and ensure qualitative earnings growth," commented Berka. This revenue and earnings development will be driven by growth in the Group's business in Asia and the launch of additional new products.

The financial report is available in full at http://berichte.analytik- jena.de/AnnualReport1112.pdf.

Contact: André Mühlig Phone: +49 36 41 77-92 81 Fax: +49 36 41 77-99 88 ir@analytik-jena.de www.analytik-jena.com

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Analytik Jena AG via Thomson Reuters ONE [HUG#1665800]

--- End of Message ---

Analytik Jena AG Konrad-Zuse-Straße 1 Jena Germany

WKN: 521350 ;ISIN: DE0005213508;Index:Prime All Share; Listed: Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Bayerische Börse München, Freiverkehr in Niedersächsische Börse zu Hannover, Prime Standard in Frankfurter Wertpapierbörse, Regulierter Markt in Frankfurter Wertpapierbörse;

http://www.analytik-jena.de (END) Dow Jones Newswires

   December 18, 2012 02:03 ET (07:03 GMT)- - 02 03 AM EST 12-18-12